Procalcitonin: seeking a niche
- PMID: 19519928
- PMCID: PMC2717415
- DOI: 10.1186/cc7799
Procalcitonin: seeking a niche
Abstract
For over a decade there has been intense interest given to the role of procalcitonin in the diagnosis and management of sepsis in critically ill patients. Early opinions strongly supported the diagnostic role but data accumulating from numerous subsequent studies are less supportive, even when used in very selective settings. Although there remains sufficient reason to support the use of procalcitonin in guiding antibiotic therapy or perhaps providing prognostic information, it may be time to focus our efforts on the early diagnosis of sepsis in the critically care setting on alternative, more promising methods.
Comment on
-
Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study.Crit Care. 2009;13(2):R37. doi: 10.1186/cc7749. Epub 2009 Mar 16. Crit Care. 2009. PMID: 19291300 Free PMC article.
References
-
- Brodska H, Drabek T, Malickova K, Kazda A, Vitek A, Zima T, Markova M. Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before haematopoietic stem cell transplantation does not indicate sepsis: a prospective study. Crit Care. 2009;13:R37. doi: 10.1186/cc7749. - DOI - PMC - PubMed
-
- Jensen J-U, Lundgren B, Hein L, Mohr T, Petersen PL, Andersen LH, Lauritsen AO, Hougaard S, Mantoni T, Bømler B, Thornberg KJ, Thormar K, Løken J, Morten Steensen M, Peder Carl P, J Asger Petersen JA, Hamid Tousi H, Peter Søe-Jensen P, Bestle M, Hestad S, Andersen MH, Fjeldborg P, Larsen KM, Rossau C, Thomsen CB, Østergaard C, Kjær J, Grarup J, Lundgren JD. The Procalcitonin and Survival Study (PASS) BMC Infect Dis. 2008;8:91. doi: 10.1186/1471-2334-8-91. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
